20.6 C
New York
Thursday, June 18, 2026

Tag: progress

Nuclear Fusion Market worth $33.77 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 12, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the global Nuclear Fusion Market size is projected to grow from USD 18.00 billion in 2026...

PAM Health announces plans to open 42-bed medical rehabilitation hospital in West Columbia, South Carolina

ENOLA, Pa., June 12, 2026 /PRNewswire/ -- PAM Health, a national leader in healthcare services, has announced plans to develop a 42-bed physical medicine...

The Galien Foundation Honours Leaders in Life Sciences Innovation with the 2026 Prix Galien UK Awards

-- Winners across biotechnology, digital health, medical technology, pharmaceuticals, public sector, and health equity categories honoured at prestigious Awards Ceremony LONDON, June 12, 2026...

EAACI Calls for a “Vision Zero” Future Free from Allergy and Asthma Burden

Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases
Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases

Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab...

Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and...

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile —

Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis

Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis

Pioneering Higher Education Technology Firm Stellic Named 2026 Student Success Platform of the Year

Award-winning platform is now helping more than 1 million students navigate complex academic journeys, make informed decisions, and chart clearer pathways to graduation and...

Global Energy Show Canada 2026 Convenes Global Energy Leaders to Advance Investment, Partnerships and Energy Security

More than 38,000 attendees from over 100 countries gathered in Calgary for Global Energy Show Canada 2026

Mondelēz International Scales Up Human Rights Due Diligence Across Own Operations and Supply Chain

Releases Annual 2025 Progress Report
Releases Annual 2025 Progress Report 

Momentum Technologies and Aquatech Form Strategic Partnership to Accelerate Domestic Critical Mineral Refining

Collaboration combines Momentum's and Aquatech's proprietary technologies and EPCM capabilities to deliver America's first end-to-end critical mineral processing platform.CARROLLTON, Texas, June 11, 2026 /PRNewswire/...

The Truth About Global Brands

Truth Is Everything: 72% of People Say It's More Important than Ever to Prioritize TruthResearch from McCann and Economist Enterprise reveals global growth will be driven by brands' ability to eliminate doubt and connect with the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgress